🔗 Permalink

Inventor profile of:

Daniel Cravo

City:

Montesson

Country:

France

Published Applications:

Last publication date:

2018-06-21

Top Assignees for applications by Daniel Cravo

The entities that hold a legal rights for patent applications filed by inventor Cravo Daniel:

Poxel 7 Lyons, France
POXEL 4 Lyon, France
Centre National de la Recherche Scientifique (CNRS 2 Paris, France
INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 2 Paris, France
ENS—ECOLE NORMALE SUPÉRIEURE DE LYON 2 Lyons, France
EDELRIS 2 Lyons, France
UNIVERSITÉ CLAUDE BERNARD LYON 1 1 Villeurbanne, France
UNIVERSITE CLAUDE BERNARD LYON 1 1 Villeurbann, France
Poxel SAS 1 Lyons, France
POXEL SAS 1 Lyon, France
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 1 Paris Cedex 13, France
INSERM (Institut National de la Sante et de la Recherche Medicale) 1 Paris Cedex, France

Recent patent applications by Cravo Daniel

Daniel Cravo from Montesson, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-06-21

US20180169115A1

Human necessities

Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection

#2 | 2016-08-04

US20160220586A1

Human necessities

Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection

#3 | 2015-06-18

US20150166566A1

Chemistry; metallurgy

Thienopyridone derivatives useful as activators of AMPK

#4 | 2013-10-03

US20130261300A1

Chemistry; metallurgy

Separation of triazine derivatives enantiomers using tartaric acid

#5 | 2013-05-23

US20130131066A1

Human necessities

Treatment of type 1 diabetes

#6 | 2013-05-23

US20130131065A1

Human necessities

TREATMENT OF TYPE 2 DIABETES

#7 | 2013-02-28

US20130053401A1

Chemistry; metallurgy

Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof

#8 | 2012-05-17

US20120122873A1

Human necessities

Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases

#9 | 2012-03-22

US20120071655A1

Chemistry; metallurgy

Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization

#10 | 2011-09-29

US20110236317A1

Chemistry; metallurgy

Tetrahydrotriazine compounds for treating diseases associated with AMPK activity

#11 | 2010-09-16

US20100233255A1

Human necessities

Combination of triazine derivatives and insulin secretion stimulators

#12 | 2010-07-01

US20100168115A1

Human necessities

Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect

InventorID:

116331 ⎘